Comments on Histologic Predictors of Fibrosis Progression in Posttransplant Hepatitis C Recurrence (original) (raw)

Fibrosis progression after liver transplantation in patients with recurrent hepatitis C

Peter Neuhaus

Journal of Hepatology, 2004

View PDFchevron_right

Impact of Fibrosis Progression on Clinical Outcome in Patients Treated for Post- Transplant Hepatitis C Recurrence

William Sanchez

Liver international : official journal of the International Association for the Study of the Liver, 2015

View PDFchevron_right

Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: A retrospective analysis of 939 liver biopsies in a single center

Olivier Guillaud

Liver Transplantation, 2007

View PDFchevron_right

Serum Fibrosis Markers Identify Patients With Mild and Progressive Hepatitis C Recurrence After Liver Transplantation

Guillermo Fernández-varo

Gastroenterology, 2010

View PDFchevron_right

Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus

Norah Terrault

Liver Transplantation, 2011

View PDFchevron_right

Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment

Detlef Schuppan

Journal of Hepatology, 2013

View PDFchevron_right

Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation

Ferran Torres

Hepatology, 2009

View PDFchevron_right

Fibrosis progression in initially mild chronic hepatitis C

Franco Noventa

Journal of Viral Hepatitis, 2006

View PDFchevron_right

Progression of fibrosis in untreated patients with hepatitis C virus infection

Gunnar Norkrans

Liver International, 2002

View PDFchevron_right

Histologic Predictors of Fibrosis Progression in Liver Allografts in Patients With Hepatitis C Virus Infection

Kimberly Forde

Clinical Gastroenterology and Hepatology, 2010

View PDFchevron_right

Early periportal sinusoidal fibrosis is an accurate marker of accelerated HCV recurrence after liver transplantation

Rosa Miquel

Journal of Hepatology, 2014

View PDFchevron_right

Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C

Rolland Dickson

Liver Transplantation, 2008

View PDFchevron_right

Antiviral therapy and fibrosis progression in patients with mild–moderate hepatitis C recurrence after liver transplantation. A randomized controlled study

Patrizia Burra

Digestive and Liver Disease, 2012

View PDFchevron_right

Fibrosis and disease progression in hepatitis C

Nathalie Boyer

Hepatology, 2002

View PDFchevron_right

Prospective non-invasive follow-up of liver fibrosis in patients with chronic hepatitis C

Corina Radu

Journal of gastrointestinal and liver diseases : JGLD, 2012

View PDFchevron_right

Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence

Rolland Dickson, Victor Machicao

Liver Transplantation, 2011

View PDFchevron_right

Sustained and continued improvement in hepatic fibrosis beyond the first year following hepatitis C virus treatment

ONKAR KSHIRSAGAR

Journal of Hepatology, 2018

View PDFchevron_right

Longitudinal assessment of hepatic fibrosis in responders to direct-acting antivirals for recurrent hepatitis C after liver transplantation using noninvasive methods

Mona Amir

Clinical transplantation, 2018

View PDFchevron_right

Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after SVR in recurrent hepatitis C

Antoni Rimola

Hepatology (Baltimore, Md.), 2017

View PDFchevron_right

One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection

Jonathan Shuster

Liver Transplantation, 2004

View PDFchevron_right

Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies

Aline Gonzalez Vigani

Hepatic Medicine : Evidence and Research, 2018

View PDFchevron_right

Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C

Miquel Bruguera

Liver Transplantation, 2007

View PDFchevron_right

Histological factors that predict the liver fibrosis in patients with chronic hepatitis C

Mircea-Catalin Fortofoiu

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2016

View PDFchevron_right

Long term changes in liver histology following treatment of chronic hepatitis C virus

Richard Sterling

Annals of Hepatology, 2014

View PDFchevron_right

Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study

Nathalie Sturm

Liver International, 2010

View PDFchevron_right

Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis

Faouzi Saliba

Liver Transplantation, 2008

View PDFchevron_right

Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C

Filiz Akyüz

Journal of Viral Hepatitis, 2013

View PDFchevron_right

Fibrosis Regression Post Direct-acting Antiviral Treatment in Hepatitis C Virus Patients

Nurhan Demir

Medical journal of Bakirköy, 2023

View PDFchevron_right